Strikingly, the high expression of CTD-2288O8.1 was closely enriched in immune-related biological terms, including the CD8+ T-cell activity, B-cell-mediated immunity, and immune response to tumor cells (Figure 7A). This evidence concerns the gene CD8A and neoplasm.